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Introduction
Our environment is characterized by recurring daily changes caused by the rotation of the earth. To optimally adjust their behavior, metabolism, and physiology to such predictable environmental changes, most living organisms evolved internal timekeeping systems, so-called circadian clocks. Cells of most tissues express clock genes in a ca. 24 hr rhythm. The hypothalamic suprachiasmatic nucleus (SCN) is the center of this clock network (1) . The SCN regulates the period and the phase of all other clocks in the brain and the rest of the body and synchronizes them with the external light/dark cycle. However, neuronal pathways conveying retinal photic input also reach other brain regions, as well as peripheral tissues like the adrenal, and recent evidence suggests that these pathways may allow non-SCN clocks to remain synchronized even when the SCN clock is non-functional (2) (3) (4) (5) (6) .
Major depressive disorder (MDD) and bipolar disorder are associated with disturbed circadian rhythms, indicated by disruptions of daily processes like sleep, appetite, and hormonal release (7) (8) (9) (10) (11) and weaker rhythms of clock gene expression in brains of MDD patients (12) . However, whether disruptions of circadian clocks are causes or consequences of mood disorders remains elusive (13) . Exposing rats to chronic mild stress to induce depression-like behavior reduces amplitude of locomotor activity, body temperature, and corticosterone rhythms (14, 15) . In mice, chronic mild stress reduces circadian rhythm amplitude in the SCN and basolateral amygdala, but increases amplitude in the nucleus accumbens (16, 17) . On the other hand, other studies suggest that circadian rhythm abnormalities may cause mood disorders. In humans, environmental disruption of circadian rhythms, such as in shift work, increases the risk of depression (18) . Mice with genetically disturbed circadian clocks often show depression-or manic-like behavior. However, due to pleiotropic, non-circadian functions of clock genes, mood phenotypes of such mice cannot be attributed unequivocally to circadian disruption. Moreover, clock gene mutations producing similar circadian phenotypes do not always produce similar mood-related phenotypes (13) . Manipulating lighting conditions also leads to changes of both circadian and moodrelated behavior (19) . However, light/dark manipulations can have substantial impact on mood regulation independent of circadian clocks, e.g. by causing cell death or neurotransmitter switching of neurons in mood-regulating brain areas, or increased inflammatory factors (19) (20) (21) . Lesions of the SCN lead to reduced behavioral despair (22) . However, SCN lesions also destroy neurons and disrupt neuronal connections, including photic input pathways to other brain regions that have functions other than circadian rhythm regulation (23) . In fact, SCN lesions can actually reverse the behavioral effects of SCN rhythm disruption in memory tasks, perhaps because an anatomically intact but dysrhythmic SCN produces an actively disruptive output signal (24) .
In this study we present a mouse model with Bmal1 shRNA-induced suppression of circadian rhythms restricted to the SCN. Since these mice developed normally, were kept under normal lighting conditions, and had intact light input pathways, intact SCN neurons and efferent connections, and intact molecular clocks outside the SCN, we can exclude many of the sorts of non-circadian effects caused by global knockouts of clock genes, light/dark manipulations, or SCN lesions. Our data reveal that selectively disturbing rhythms in the SCN master circadian pacemaker causes helplessness, behavioral despair, and anxiety-like behavior, as well as increased sensitivity to stress.
Materials and methods

Animals
All experiments were done in 8-14 week old male mPer2 Luciferase (PER2::LUC) mice. In PER2::LUC knockin mice, the wild type (WT) circadian clock gene Period2 (Per2) has been replaced by homologous recombination with a construct incorporating the firefly luciferase (Luc) gene in tandem with WT Per2, such that a bioluminescent PER2::LUC fusion protein is expressed under control of all Per2 regulatory elements (25) . In our mice, the reporter construct also incorporated an SV40 polyadenylation site to enhance expression levels (26) , and mice were backcrossed to produce a congenic C57BL/6J background. Unless otherwise stated, mice were maintained in LD 12:12 cycles (12 h light, 12 h dark).
Beginning 6 days before stereotaxic AAV injections, mice were single-housed with continuous access to water and food. We attempted to minimize the number of animals used and animal pain and distress.
Mouse studies were conducted in accordance with regulations of the Institutional Animal Care and Use Committee at University of California, San Diego.
Virus production
To make cDNA encoding our small hairpin RNAs (shRNA) and suitable to produce adeno-associated virus (AAV) vectors, we first PCR amplified a sequence encoding the U6 promoter, the scrambled 19nucleotide shRNA sequence, and the cytomegalovirus/green fluorescent protein (CMV/GFP) cassette from pLL3.7 vector (pLL3.7 Scr shRNA was a gift from Dr. Ulrike Heberlein, University of California, San 
Virus injection
Mice were anesthetized with ketamine/dexmedetomidine in 0.9% saline (ketamine: 70 mg per kg body weight; dexmedetomidine: 0.3 mg per kg body weight) before bilateral stereotaxic injection of AAV particles in the SCN (anteroposterior: 0.46 mm posterior to bregma; mediolateral: 0.2 mm lateral to midline; dorsoventral: 5.5 mm below dura). About 0.5-0.8 μl of virus was injected into each position over ~30 min using a picospritzer (Parker). All mice received a mixture of two shRNAs: either both Bmal1 or both scrambled shRNAs. To allow diffusion of the virus, the injection pipette remained immobile for 1 min before moving more ventral, and for 3 min before removing it. After surgery, mice were injected with 0.05 mg atipamezole for reversal of dexmedetomidine. Efficiency of Bmal1-KD was determined as described in supplemental materials.
Behavioral tests
To measure locomotor activity rhythms, SCN-Bmal1-KD and control mice were singly housed in running wheel-equipped cages, and locomotor activity was monitored under different lighting conditions. During the first 6 days, mice were maintained in LD 12:12 cycles (12 h light, 12 h dark) with light levels at 200 lux. Subsequently, mice were kept in constant darkness (DD) for 13 days. Sucrose preference, open field test, tail suspension test, and learned helplessness were performed as described previously (27) .
Detailed descriptions of these and other behavioral tests are provided in supplemental materials.
Sucrose preference tests were performed twice per week with 1% sucrose water starting 6 days before AAV injections and continuing until mice were sacrificed at the end of all experiments. All other behavioral tests started three weeks after AAV injections to allow time for full expression of Bmal1
shRNA. Testing began with the least stressful tests, followed by the more stressful tests, and finally the most stressful procedure, induction of learned helplessness.
Brain slice culture and PER2::LUC measurements
After all behavioral tests were complete, mice were anesthetized with isoflurane and killed by cervical dislocation, and organotypic SCN explants were prepared as described previously (28) . PER2::LUC expression patterns were measured using a LumiCycle luminometer (Actimetrics, Wilmette, IL, USA) as described previously (28) .
Blood sampling and corticosterone measurements
Details about the preparation of blood samples are provided in supplemental materials. Corticosterone concentrations were measured using a commercially available RIA kit (MP Biomedicals, Santa Ana, CA, USA). Plasma samples were diluted 1:200.
24-hour profile:
Mice were transferred to a separate room 1 day before blood sampling began. Lights were turned off at the regular time of the LD 12:12 light/dark cycle, and then remained off until all blood samples were collected. Blood was sampled every four hours beginning at CT1 (7:00 AM) under dim red light. During sampling, mice were not restrained and were allowed to explore the bench area freely.
Restraint stress: To measure stress-related corticosterone release, mice were transferred to mouse restrainers (Plas Labs, Lansing, MI, USA) for 30 min. Blood was collected immediately before restraint stress (0 min), and after 10 min, 30 min, 60 min, and 90 min of restraint. All blood samples were collected between 6 and 9 hrs after lights on.
Data analysis
Statistical analyses were conducted using GraphPad Prism (GraphPad Software, La Jolla, CA, USA).
Corticosterone release profiles were fit to Fourier curves with 2 harmonics using CircWave (developed by Roelof Hut, University of Groningen, Netherlands). Bioluminescence data were analyzed using LumiCycle Analysis software (Actimetrics, USA). Amplitude was determined over 5 days by fitting a sine wave [LM fit (Sin)] to 24 h running average baseline-subtracted data. In order to normalize amplitude to the size of cultured tissues, the sine wave amplitude was divided by the baseline bioluminescence brightness of each individual explant. The first day of measurement was excluded from analyses. Wheel-running activity was analyzed using ClockLab software (Actimetrics, USA). The first 3 days of the DD condition were excluded from analysis. Data that were significant outliers (p<0.05) in the Grubb's test and >3 standard deviations from the mean of the remaining values were excluded. Details about statistical tests used for individual experiments are indicated in figure legends.
Results
SCN Bmal1-KD in vivo suppresses PER2::LUC rhythmicity in vitro
To test the effect of disrupted SCN clocks on mood-related behaviors in mice, we generated AAV vectors encoding shRNAs designed to target and downregulate Bmal1 expression ( Fig. 1A) . The Bmal1-shRNA reduces BMAL1 protein levels by ~60% ( Fig. 1B, C) . After all behavioral experiments were completed, we sacrificed the animals and prepared organotypic SCN explants. We used these explants to confirm the correct injection site of the AAV particles and to determine the efficiency of the Bmal1-KD for each individual animal. The injection site was identified by the GFP reporter that was encoded by all of our AAV vectors ( Fig. 1D, S1A , B). Animals that showed no GFP expression in the SCN were excluded from analyses ( Fig. S1C ). Reduced amplitude of PER2::LUC rhythms in SCN explants provided a quantitative estimate of the efficiency of Bmal1 knockdown. In mice injected with Bmal1 shRNA, amplitude of SCN PER2::LUC rhythms was decreased by ~80% and period was lengthened compared to control mice injected with scrambled sequence shRNA ( Fig. 1E, F) . Of ten mice with successfully targeted Bmal1 shRNA, SCN rhythms were of drastically reduced amplitude in nine, and completely absent in one. SCN-Bmal1-KD mice did not show GFP expression outside of the SCN, suggesting that non-SCN brain areas had intact molecular clocks ( Fig. S2 ). To confirm that molecular clocks outside the SCN were not deficient, we cultured periaqueductal gray (PAG) explants from SCN-Bmal1-KD and control mice. The PAG was shown previously to express stable circadian rhythms in culture (28) . We found that PAG explants from SCN-Bmal1-KD mice and control mice were equally rhythmic (66.7% vs. 70% of slices rhythmic, n=12 and 10, respectively), indicating that molecular clocks in brain areas outside of the SCN were still functional despite SCN-specific Bmal1-KD.
To test effects of SCN-specific Bmal1-KD on behavioral rhythms, mice were transferred to DD to monitor the endogenous SCN-driven ("free-running") locomotor activity rhythm with running wheels. Like SCN explants from these mice, SCN-Bmal1-KD mice on running wheels exhibited a significantly longer circadian period compared to control mice, but did not show any other circadian locomotor rhythm abnormalities ( Fig. 1G , H, S3).
To assess for possible tissue damage caused by the injection procedure or toxicity of shRNAs, injected and uninjected SCN explants were compared, and showed no differences in either histological appearance by bright field microscopy or amplitude of PER2::LUC rhythms. To assess for possible toxicity specific to Bmal1 shRNA, SCN explants injected with Bmal1 shRNA vs. scrambled sequence shRNA were compared, and showed no differences in either cell morphology or 24 hr mean level of PER2::LUC bioluminescence, which is an ATP-requiring enzymatic reaction requiring cell viability. Thus, injection of shRNAs did not adversely affect anatomical structure of the SCN or viability of SCN neurons. These results confirm that AAV-directed downregulation of Bmal1 is sufficient to impair circadian rhythms in SCN and constitute a good model to test the impact of impaired SCN circadian rhythms on mood-related behavioral changes in mice.
Disrupting SCN rhythms causes helplessness, behavioral despair, anxiety-like behavior, and weight gain
Three weeks after the shRNA injections, mice underwent behavioral tests to determine the effects of disrupting SCN circadian rhythms on mood. Beginning six days before shRNA injection, we also performed a sucrose preference test twice a week in order to test for gradual changes in hedonic responses to sucrose ( Fig. 2A ). In the learned helplessness paradigm, reduced SCN rhythm amplitude induced by Bmal1-KD led to significant increases in escape latencies and number of escape failures ( Fig.   2A ). Mice with disrupted SCN rhythms also showed a significantly higher immobility time in the tail suspension test compared to control animals (Fig. 2B ). In the light/dark box test, SCN-Bmal1-KD mice spent significantly less time in the light compartment ( Fig. 2F) , indicating increased anxiety-like behavior, but were not impaired in their spatial preference or total activity in the open field test (Fig. 2G ).
Since mood disorders are often associated with metabolic disorders, we also tested weight gain and found that over the course of five weeks, SCN-Bmal1-KD mice gained significantly more weight than control mice (Fig. 2C ). Knockdown of Bmal1 in the SCN had no significant impact on preference for sweet sucrose water at any time point (sucrose preference test) ( Fig. 2D) , nor on the latency to approach and eat food in a novel environment (novelty-suppressed feeding test) ( Fig. 2E ). In this test, total food uptake was similar in SCN-Bmal1-KD and control mice.
Inescapable stress is not required for helpless behavior in SCN-Bmal1-KD mice
Because some mood-related behavior changes in SCN-Bmal1-KD mice were evident before IS, we investigated the importance of stress in more detail by testing for helplessness even in the absence of IS in a new group of SCN-Bmal1-KD and control mice. In these experiments, we tested active avoidance by performing only the testing phase of the learned helplessness paradigm, in which animals always had the opportunity to escape. Even without any previous exposure to IS, SCN-Bmal1-KD mice displayed decreased active avoidance, with significantly longer escape latencies and more failures compared to control mice (Fig. 3) . Thus, helplessness appears to develop spontaneously in SCN-Bmal1-KD mice.
Importantly, when testing sensitivity to gradually increasing electric shock intensity, SCN-Bmal1-KD and control mice displayed no differences, demonstrating that the differences in active avoidance were not due to altered pain sensitivity (Fig. S4 ).
Stress response system is altered in SCN-Bmal1-KD mice
The circadian clock and the stress response system are closely related, and abnormal glucocorticoid levels are associated with the development of mood disorders (29) . For this reason we investigated diurnal plasma corticosterone rhythms of SCN-Bmal1-KD and control mice under constant environmental conditions as well as corticosterone release in response to restraint stress. Control animals showed a single clear corticosterone peak at the beginning of their subjective night when they normally become active (25 hours after "lights off"). In contrast, SCN-Bmal1-KD mice showed a second, even more pronounced, rise of corticosterone towards the end of their subjective night (33 hours after "lights off"). A 2-way ANOVA revealed a significant difference between the two groups over the time course studied (p=0.01) (Fig. 4A ). When we stressed the mice by transferring them into a restrainer, SCN-Bmal1-KD and control mice showed a similar increase of corticosterone after the first 10 min of stress. However, after 30 min of stress, SCN-Bmal1-KD mice displayed significantly lower corticosterone levels than control mice. Analyses of these data by 2-way ANOVA indicate a statistically significant difference between SCN-Bmal1-KD and control mice (p=0.0242) (Fig. 4B ).
Discussion
In this study we investigated whether disrupting rhythms in the central SCN circadian clock alters moodrelated behavior. Mechanistic connections between disturbed circadian clocks and mood regulation have been evaluated before in rodent models (7, 8, 11) . However, in previous studies it was not clear whether circadian or non-circadian changes led to abnormal mood-related behavior (13) . Manipulations of lighting conditions, light input pathways, or expression of genes involved in circadian rhythms always involve consequences that are independent of the actual diurnal oscillations produced by intrinsic circadian clocks. In contrast, our study provides an animal model with normally developed, anatomically intact brain and light input pathways, and intact molecular clock gene machinery in all non-SCN brain regions and peripheral tissues, under normal LD 12:12 lighting conditions. To create such a model, we Bmal1-KD SCN explants generally still showed significant circadian rhythms, but with ~80% lower amplitude and longer period compared to control SCN explants. Accordingly, SCN-Bmal1-KD mice still showed circadian activity rhythms in DD, but with longer free-running periods. Interestingly, many MDD patients display decreased circadian rhythm amplitude (30) and abnormally delayed melatonin (31, 32) and behavioral rhythms (33) . It is well known that longer free-running period is typically associated with delayed phase of entrainment, suggesting that MDD patients may also have abnormally long circadian periods. However, the locomotor activity rhythm is just one output of the central clock in the SCN. In view of strongly attenuated SCN rhythm amplitude, it is quite possible that other SCN-regulated rhythms are more strongly affected than locomotor activity rhythms. Furthermore, long circadian SCN period in SCN-Bmal1-KD mice may promote internal desynchrony among brain areas and other tissues whose clocks are genetically intact. Circadian misalignment among brain regions could contribute to the development of mood-related abnormalities (9, 28) . Thus, in our mouse model, circadian rhythms in the SCN were greatly weakened and period was lengthened, but rhythms were not completely eliminated, a realistic model of the kind of disruption most likely to occur in humans.
Disrupting circadian rhythms of the central circadian pacemaker in the SCN causes several robust moodrelated behavioral changes. In particular, compared to control mice injected with a scrambled sequence shRNA, SCN-Bmal1-KD mice exhibit increases in behavioral despair, anxiety-like behavior, and helplessness. Even before mice are exposed to the inescapable stress (IS) of the learned helplessness induction procedure, SCN-Bmal1-KD mice already show significantly increased immobility times in the tail suspension test, conventionally interpreted as a sign of increased behavioral despair (although this interpretation is controversial) (23, 34) . In addition, disrupting central circadian rhythms leads to increased anxiety-like behavior in the light/dark box test, manifesting as avoidance of a potentially dangerous environment. Furthermore, SCN-Bmal1-KD mice are more helpless than control mice, showing increased latencies or failures to escape foot shock. Importantly, running wheel activity measurements and the open field test revealed that our SCN-specific Bmal1-KD procedure does not alter levels of general locomotor activity. Just as for behavioral despair and anxiety-like behavior, helplessness in SCN-Bmal1-KD mice is already present at baseline, even before they are subjected to IS training. Although exposure to IS is usually seen as being essential for "learned helplessness", "congenital helpless" rats have been characterized that display increased active avoidance latencies and other signs of depression-like behavior without induction by IS (35) . Accordingly, SCN-Bmal1-KD mice represent a new genetic animal model of helplessness, despair, and anxiety.
Not all mood-related behaviors are altered in SCN-Bmal1-KD mice. Hedonic behavior in the sucrose preference test, spatial preference in the open field test, and aversion to eating in a novel environment are all similar in SCN-Bmal1-KD and control mice. This indicates that specific aspects of mood-related behavior are influenced differently by the suppression of SCN circadian rhythms.
Since the SCN is not known to be directly involved in mood regulation, it is likely that disruption of the central clock affects mood by causing disturbed circadian rhythms in downstream systems that regulate mood more directly (9). One such system is the HPA axis, which is tightly associated with both the circadian clock and mood regulation (29) . In this study we show that mice with disrupted SCN rhythms have abnormally high corticosterone levels toward the end of their subjective night, manifesting as a second peak of corticosterone release in addition to the expected rise at the beginning of the subjective night. Another study investigated corticosterone levels in a different SCN clock-deficient mouse model achieved by neuron-specific knockout of Bmal1 using Cre recombinase expressed under a Syt10 promoter (3) . In that study, performed in a light/dark cycle, corticosterone rhythms were not different in SCN clock-deficient and control mice, suggesting that the light/dark cycle may compensate for the loss of SCN rhythms by directly modulating corticosterone release (3) (4) (5) . Because our experiment was carried out in constant darkness, without potential "masking" influences of light, we were able to detect more directly the impact of SCN rhythms on rhythmic release of corticosterone from the adrenals. We found that SCN-Bmal1-KD mice display a reduced corticosterone response to stress, suggesting an essential role of the SCN clock in this response. This blunted corticosterone response to stress could explain the helpless behavior of SCN-Bmal1-KD mice, as attenuated levels of corticosterone were previously associated with escape deficits in learned helplessness (36) (37) (38) . Thus, low amplitude SCN rhythms may cause changes in mood-related behavior at least in part by altering corticosterone levels at baseline and in response to stress.
Another possibility is that knockdown of the SCN central circadian pacemaker leads to disturbed rhythms in downstream brain areas that are more directly involved in mood regulation (9, 28) . Such brain areas are likely to harbor less stable clocks than the SCN (39) , and their circadian oscillations may therefore be extremely disturbed in the presence of low amplitude SCN rhythms. Indeed, in a recent study we found that certain brain regions implicated in mood regulation do indeed show disrupted rhythms in helpless mice (28) . Most mice that become helpless in the learned helplessness procedure exhibit an absence of circadian rhythms in the nucleus accumbens and the periaqueductal gray.
However, it remains to be determined whether disrupting circadian rhythms specifically in these areas, individually or in combination, is sufficient to cause changes in mood-related behavior.
Finally, we found that SCN-Bmal1-KD mice display increased weight gain, despite unchanged food intake. Importantly, many psychiatric disorders, including MDD, are associated with metabolic disturbances and obesity (40) . Because circadian clocks control both affective and metabolic functions, we previously suggested that disturbed circadian rhythms may play an important role in mediating the comorbidity of metabolic and psychiatric disorders (40) . Although our results are preliminary, they support the hypothesis that disturbed circadian rhythms lead to both mood-related and metabolic abnormalities simultaneously in SCN-Bmal1-KD mice.
Our data provide evidence that disturbed circadian clocks are sufficient for the development of depression-like behavior in different behavioral tests, helplessness at baseline as well as after stress, anxiety-like behavior, and weight gain. By using a mouse model with genetic disruption of circadian rhythms specific to the SCN but normal brain development and anatomy and a normal light/dark environment, we can exclude pleiotropic effects of clock genes in mood-regulating systems, loss of neuronal connections, and light-related factors in the development of mood-related behavioral abnormalities. Our data suggest that disturbed clocks impact the stress system, and probably also circadian oscillators in mood-regulating brain areas, which may explain the increase of helplessness, behavioral despair, and anxiety-like behavior in SCN-Bmal1-KD mice (Fig. 5 ). Future studies of non-SCN clocks in the stress system and other brain regions may provide more targeted chronotherapies for patients with mood disorders. 
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